Page last updated: 2024-09-05

enzastaurin and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone

enzastaurin has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 2 studies

Compound Research Comparison

Studies (enzastaurin)	Trials (enzastaurin)	Recent Studies (post-2010) (enzastaurin)	Studies (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone)	Trials (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone)	Recent Studies (post-2010) (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone)
188	52	99	1,897	0	411

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Davies, KM; Ghias, K; Krett, NL; Ma, C; Munshi, HG; Rizvi, MA; Rosen, ST; Weinberg, F	1
Frank, B; Lemke, D; Maurer, G; Rieger, J; Tabatabai, G; Weiler, M; Weller, M; Wick, W	1

Other Studies

2 other study(ies) available for enzastaurin and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone

Article	Year
Enzastaurin (LY317615), a protein kinase Cbeta inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines. Molecular cancer therapeutics, 2006, Volume: 5, Issue:7 Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cell Proliferation; Dexamethasone; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Insulin-Like Growth Factor I; Interleukin-6; Multiple Myeloma; Phosphorylation; Protein Kinase C; Protein Kinase C beta; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction	2006
Enzastaurin-induced apoptosis in glioma cells is caspase-dependent and inhibited by BCL-XL. Journal of neurochemistry, 2008, Volume: 106, Issue:6 Topics: Adult; Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; bcl-X Protein; Brain Neoplasms; Caspases; Cell Line, Tumor; Cytochromes c; Drug Resistance, Neoplasm; Enzyme Inhibitors; Glioma; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Mitochondria; Protein Kinase C; Proto-Oncogene Proteins c-akt; Receptors, TNF-Related Apoptosis-Inducing Ligand	2008

Article

Year

Enzastaurin (LY317615), a protein kinase Cbeta inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines.

Molecular cancer therapeutics, 2006, Volume: 5, Issue:7

Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cell Proliferation; Dexamethasone; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Insulin-Like Growth Factor I; Interleukin-6; Multiple Myeloma; Phosphorylation; Protein Kinase C; Protein Kinase C beta; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction

2006

Enzastaurin-induced apoptosis in glioma cells is caspase-dependent and inhibited by BCL-XL.

Journal of neurochemistry, 2008, Volume: 106, Issue:6

Topics: Adult; Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; bcl-X Protein; Brain Neoplasms; Caspases; Cell Line, Tumor; Cytochromes c; Drug Resistance, Neoplasm; Enzyme Inhibitors; Glioma; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Mitochondria; Protein Kinase C; Proto-Oncogene Proteins c-akt; Receptors, TNF-Related Apoptosis-Inducing Ligand

2008